V001-4938 Screening compound: 4-methyl-N-[3-(morpholin-4-yl)propyl]-N-(2-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)benzamide

V001-4938 Screening compound: 4-methyl-N-[3-(morpholin-4-yl)propyl]-N-(2-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)benzamide
V001-4938 Screening compound: 4-methyl-N-[3-(morpholin-4-yl)propyl]-N-(2-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V001-4938
4-methyl-N-[3-(morpholin-4-yl)propyl]-N-(2-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V001-4938

Molecular Formula

C26H29F3N4O3 (C26 H29 F3 N4 O3)

Compound Name

4-methyl-N-[3-(morpholin-4-yl)propyl]-N-(2-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)benzamide

IUPAC name

4-methyl-N-[3-(morpholin-4-yl)propyl]-N-(2-{3-[3-(trifluoromethyl)phenyl]-124-oxadiazol-5-yl}ethyl)benzamide

SMILES

Cc(cc1)ccc1C(N(CCCN1CCOCC1)CCc1nc(-c2cccc(C(F)(F)F)c2)no1)=O

InChI

InChI=1S/C26H29F3N4O3/c1-19-6-8-20(9-7-19)25(34)33(12-3-11-32-14-16-35-17-15-32)13-10-23-30-24(31-36-23)21-4-2-5-22(18-21)26(27,28)29/h2,4-9,18H,3,10-17H2,1H3

InChI Key

CRBQKZIRFDICLA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19782051

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

502.54

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.480

Distribution Coefficient, logD

4.257

Water Solubility, LogSw

-4.39

Polar Surface Area

59.369

Acid Dissociation Constant (pKa)

27.84

Base Dissociation Constant (pKb)

7.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.30

V001-4938 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V001-4938 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V001-4938?
Check Price and Availability of V001-4938, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V001-4938 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V001-4938
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V001-4938
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V001-4938 available by request